Core summary of product characteristics for human plasma derived antithrombin

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/BPWG/3226/99
Published17/01/2002
Effective from01/07/2002
KeywordsCongenital antithombin deficiency, acquired antithombin deficiency, summary of product characteristics (SPC)
DescriptionThis document describes the information to be included in the summary of product characteristics for human plasma derived antithrombin.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more